Abstract

The GETUG SEMITEP Trial: De-Escalating Chemotherapy in Good-Risk Metastatic Seminoma Based on Early FDG-PET/CT

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call